Sanofi said SAR446597, its treatment for geographic atrophy due to age-related macular degeneration, was granted fast-track designation by the Food and Drug Administration. The French drugmaker said ...

Paris: Sanofi has received fast track designation from the US Food and Drug Administration (FDA) for SAR446597, a one-time ...

Age-Related Macular Degeneration Market Epidemiology Report 2025-2035: Drugs Pipeline, Therapies, and Forecast The report provides a detail ...

Sanofi’s SAR446597 earns fast track designation in the US for geographic atrophy due to age-related macular degeneration ...

AAVantgarde is now initiating ‘CELESTE’, a first-in-human Phase 1/2 clinical trial in the United States, to evaluate the safety, tolerability, and initial efficacy of AAVB-039 in patients with ...

Similar data from Social Security Scotland indicates there are now 2,010 people receiving ADP for an eye condition. An estimated 188,000 people in Scotland are affected by some form of sight loss with ...

It's not only caused by needing corrective lenses. Leading eye doctors share which conditions—big and small—can cause blurry ...

Discover advanced retina treatments at Shreya Eye Centre – the best retina hospital in Noida offering expert care for ...

HOUSTON, TX / ACCESS Newswire / July 9, 2025 / Mann Eye Institute, a leader in innovative eye care since the 1970s, is proud ...

Whether you’re a latte lover, a mocha monster or an espresso elitist — people have strong preferences when it comes to coffee ...

Alcon has inked a deal to acquire LumiThera and its light-based therapy for dry age-related macular degeneration, which ...

Objective: To investigate the risk of age-related macular degeneration (AMD) in association with optic disc drusen (ODD). Design: Observational, cross-sectional study. Participants: Consecutive ODD ...